Zobrazeno 1 - 7 of 7 pro vyhledávání: '"Branislav, Biss"'
1
Phase 3, single‐arm, multicenter study of dabigatran etexilate for secondary prevention of venous thromboembolism in children: Rationale and design
Autor: Elizabeth Chalmers, Manuela Albisetti, Martina Brueckmann, Lisa Bomgaars, Savion Gropper, Jacqueline Halton, Igor Tartakovsky, Bushi Wang, Ruth Harper, Lesley G. Mitchell, Matteo Luciani, Fenglei Huang, Ivan Manastirski, Leonardo R. Brandão, Branislav Biss
Publikováno v: Research and Practice in Thrombosis and Haemostasis
Background Anticoagulant therapy for venous thromboembolism (VTE) in children is largely based on treatment recommendations for adults. However, differences in both physiology (ie, renal maturation and drug excretion) and developmental hemostasis mus
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2f8c28968bc418667f47592eeb501ca
http://europepmc.org/articles/PMC6046601
Zobrazit plný text záznamu
2
Design and rationale for the DIVERSITY study: An open‐label, randomized study of dabigatran etexilate for pediatric venous thromboembolism
Autor: Igor Tartakovsky, Manuela Albisetti, Martina Brueckmann, Lesley G. Mitchell, Ivan Manastirski, Lisa Bomgaars, Savion Gropper, Matteo Luciani, Jacqueline Halton, Branislav Biss, Fenglei Huang, Bushi Wang, Elizabeth Chalmers, Leonardo R. Brandão, Ruth Harper
Publikováno v: Research and Practice in Thrombosis and Haemostasis
Essentials Current standard of care (SOC) for pediatric venous thromboembolism (VTE) has limitations.Dabigatran etexilate (DE) versus SOC will be studied in children with VTE in a phase IIb/III trial.A dosing algorithm for DE in children will be asse
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e29d7b1cf50d36de29b618ff9236419f
http://europepmc.org/articles/PMC6055566
Zobrazit plný text záznamu
3
Phase IIa study of dabigatran etexilate in children with venous thrombosis: pharmacokinetics, safety, and tolerability
Autor: Lisa Bomgaars, Lesley G. Mitchell, Igor Tartakovsky, Matteo Luciani, Savion Gropper, Jacqueline Halton, Ruth Harper, Manuela Albisetti, Hugo Maas, Fenglei Huang, Branislav Biss, Martina Brueckmann
Publikováno v: Journal of Thrombosis and Haemostasis. 15:2147-2157
Essentials Dabigatran etexilate may provide a new treatment option for pediatric venous thromboembolism. Children aged 1 to < 12 years were given dabigatran etexilate in an open-label, single-arm study. The pharmacokinetic–pharmacodynamic relations
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a837356d055ff9a3b51fe6f5164dea68
https://doi.org/10.1111/jth.13847
Zobrazit plný text záznamu
4
Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation
Autor: Hugh, Calkins, Stephan, Willems, Edward P, Gerstenfeld, Atul, Verma, Richard, Schilling, Stefan H, Hohnloser, Ken, Okumura, Harvey, Serota, Matias, Nordaby, Kelly, Guiver, Branislav, Biss, Marc A, Brouwer, Massimo, Grimaldi, Karen, Hirsch
Publikováno v: New England journal of medicine, 376(17), 1627-1636. Massachussetts Medical Society
The New England Journal of Medicine, 376, 1627-1636
The New England Journal of Medicine, 376, 17, pp. 1627-1636
Contains fulltext : 182933.pdf (Publisher’s version ) (Open Access) BACKGROUND: Catheter ablation of atrial fibrillation is typically performed with uninterrupted anticoagulation with warfarin or interrupted non-vitamin K antagonist oral anticoagul
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b55081f620325a410a0445eb1d13520b
https://hdl.handle.net/2066/182933
Zobrazit plný text záznamu
5
Regional differences in patient characteristics and outcomes during uninterrupted anticoagulation with dabigatran versus warfarin in catheter ablation of atrial fibrillation: the RE-CIRCUIT study
Autor: Branislav Biss, Ken Okumura, Matias Nordaby, Stephan Willems, Richard J. Schilling, Stefan H. Hohnloser, Hugh Calkins, Eva Kleine, Edward P. Gerstenfeld, Atul Verma
Publikováno v: Journal of Interventional Cardiac Electrophysiology
Purpose To describe regional differences in patient characteristics, ablation procedures, and bleeding events in the RE-CIRCUIT study. RE-CIRCUIT was a prospective, multicenter study that captured data from different regions, providing an opportunity
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0dcfe340954140ef5d81624d23adcf3
https://pubmed.ncbi.nlm.nih.gov/30758702
Zobrazit plný text záznamu
6
Rationale and Design of a Phase IIb/III Open-Label, Multicenter Study of Dabigatran Etexilate for Venous Thromboembolism in Children: The Diversity Study
Autor: Igor Tartakovsky, Fenglei Huang, Martina Brueckmann, Lesley G. Mitchell, Ivan Manastirski, Branislav Biss, Manuela Albisetti, Bushi Wang, Savion Gropper, Jacqueline Halton, Leonardo R. Brandão
Publikováno v: Blood. 128:5025-5025
Background Venous thromboembolism (VTE) is increasing in children. The current standard of care comprises unfractionated heparin (UFH) or low-molecular-weight heparin (LMWH) for at least 5 days followed by UFH, LMWH or Vitamin K antagonists (VKA) for
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::18e7d326b41acd4f69e3db1987198a1a
https://doi.org/10.1182/blood.v128.22.5025.5025
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje